Brief: Kane Biotech Inc - QTRLY Loss Per Share (Post Consolidation) $0.012
14/11/2018 23:13
Kane Biotech Inc KNE.V :
* KANE BIOTECH ANNOUNCES THIRD QUARTER 2018 FINANCIAL
RESULTS
* KANE BIOTECH INC - QTRLY LOSS PER SHARE (POST
CONSOLIDATION)
$0.012
Source text for Eikon: ID:nGNX9C6WcB
Further company coverage: KNE.V
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update